Leukotriene modifiers in the management of asthma.

M. H. Elnabtity, R. F. Singh, M. A. Ansong, Timothy Craig

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Leukotrienes play a major role in the underlying pathophysiology of asthma. Leukotriene-receptor antagonists and direct leukotriene-synthesis inhibitors may be important new agents in maintenance therapy for asthma. Their role may also extend to attenuating exercise-induced and allergen-induced bronchospasm. This article reviews the effectiveness of available leukotriene modifiers in various clinical studies, reviews their adverse effects profile, and discusses their potential roles in the management of asthma.

Original languageEnglish (US)
JournalThe Journal of the American Osteopathic Association
Volume99
Issue number7 Suppl
Publication statusPublished - Jul 1999

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this